O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data

Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim M. Linton, Martine E. D. Chamuleau, David J. Lewis, Anna Sureda Balari, David Cunningham, Roberto S. Oliveri, Dena DeMarco, Brian Elliott, Kuo-mei Chen, Pieternella J. Lugtenburg

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S292-S292
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - 26 Jul 2021

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this